Primary Immune Deficiency research hub

Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases

This study is looking at a new way to give an existing medicine, Newnorm, for people with primary immune deficiency. It's given under the skin. We want to check if it's safe, works well, and how the body uses it.